Pihlajalinna’s Q1 revenue came in 4% above estimates and helped profitability land some EUR 3m highe...
Sales above in all three consolidated holdings Loss in Point, profit in Företagsparken EPRA NRV per ...
Redeye leaves its view on Xbrane Biopharma following today’s Q1, confirming that a BLA submission to...
Redeye comments on the Q1 report from Vicore and give our view of recent events in the company.
Egen produktion fortsätter att glänsa Arise nettoomsättning uppgick till 88 (47) mkr och EBIT till 4...
Redeye states that the company’s future, Managed Services, continued its strong momentum in Q1.
Redeye expects another stable quarter from Starbreeze.
Q-linea’s partner Thermo Fisher is launching ASTar in Europe.
Redeye raises its forecasts in Addnode following a solid Q1, with solid margins in all three Divisio...
79% sales growth, of which 27% organic Adj. EBITDA SEK 2.
Redeye is positive about Catella's acquisition of WPP.
Net operating income -1% vs ABGSCe, -3% vs cons. +0.
Redeye is encouraged by yet another record quarter by BONESUPPORT, but we have made some considerabl...
Adj. EBIT +7% vs ABGSC, +11% vs cons UA/sales to increase to 35% in Q2… …lowering profit short term,...
Redeye saw sales in line with our expectations for the quarter.
Redeye gives its initial take of Paynova’s first-quarter report for 2022, which was above our growth...
Redeye comments on G5’s Q1-results which adjusted for extraordinary costs related to the war in Ukra...
ESG activities In 2022, the company renewed its sustainability strategy and will in the forthcoming ...
Company activities Eastnine aims to run a climate-neutral organisation and is targeting net zero ca...
ESG activities Trianon’s sustainability agenda focuses on five areas, based on a selection of the U...
